The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Crohn’s Disease Treatment Market?
The crohn’s disease treatment market size has experienced robust growth in recent years. It is projected to expand from $13.1 billion in 2025 to $13.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. This historical growth can be attributed to factors such as the increasing prevalence of Crohn’s disease, growing awareness of inflammatory bowel diseases, the expansion of hospital pharmacy networks, the availability of conventional anti-inflammatory drugs, and improved diagnostic capabilities.
The crohn’s disease treatment market size is forecast to show robust expansion over the next few years. It is predicted to attain $18.86 billion in 2030, progressing at a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period can be linked to the broadening pipeline for biologics and small molecules, a growing preference for personalized treatments, increased online pharmacy access, rising healthcare expenditure in emerging markets, and a focus on long-term disease management. Notable developments expected in this period include the rising adoption of biologic therapies, a shift towards earlier and more aggressive treatment approaches, an increasing emphasis on steroid-sparing regimens, the expansion of oral small-molecule therapies, and the growth of online and specialty pharmacy channels.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
Which Major Factors Are Contributing To The Development Of The Crohn’s Disease Treatment Market?
The growing occurrence of inflammatory bowel disorders is anticipated to boost the Crohn’s disease treatment market moving forward. Inflammatory bowel disorders are defined as a collection of chronic illnesses characterized by inflammation within the gastrointestinal tract, which can inflict damage and inflammation anywhere along the digestive system from the mouth to the anus. Treating Crohn’s disease aims to lessen intestinal inflammation, avert symptom flare-ups, and sustain remission. For example, a September 2023 report from the National Center for Biotechnology Information, a US government body, indicated a comparable rise in the prevalence of Crohn’s disease and ulcerative colitis. Inflammatory bowel disease is estimated at 825 cases per 100,000 people in 2023, with 410 attributed to Crohn’s disease and 414 to ulcerative colitis and IBD-u. Consequently, this increasing prevalence of such disorders is stimulating the growth of the Crohn’s disease treatment market.
How Does Segment Analysis Break Down The Crohn’s Disease Treatment Market Structure?
The crohn’s disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments
What Trends Are Influencing The Crohn’s Disease Treatment Market?
Major companies in the crohn’s disease treatment market are innovating and getting new drugs approved, such as biosimilar ustekinumab, to provide more effective and accessible treatment options for patients, ultimately improving patient outcomes and quality of life. Biosimilar ustekinumab refers to a biologic drug highly similar to the original ustekinumab, a monoclonal antibody used for treating autoimmune conditions. For instance, in July 2024, Sandoz International GmbH, a Switzerland-based pharmaceutical company, launched Pyzchiva (ustekinumab) across Europe, establishing it as the first ustekinumab biosimilar available in all strengths, including a 130 mg vial specifically for Crohn’s disease. This product is indicated for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn’s disease, enhancing Sandoz’s immunology portfolio while aiming to improve access to affordable treatments for chronic inflammatory disease.
Who Are The Major Companies Operating In The Crohn’s Disease Treatment Market?
Major companies operating in the crohn’s disease treatment market are AbbVie Inc., Janssen Pharmaceuticals, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Galapagos NV, Teva Pharmaceutical Industries Ltd., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim GmbH, Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd.
Access The Complete Crohn’s Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Which Region Has The Strongest Presence In The Crohn’s Disease Treatment Market?
North America was the largest region in the global Crohn’s disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn’s disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Crohn’s Disease Treatment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
Browse Through More Reports Similar to the Global Crohn’s Disease Treatment Market 2026, By The Business Research Company
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Crohns Disease Cd Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model